<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=217082&amp;fmt=gif">

MD Biosciences Blog

Genetics, Neuroscience and Immunotherapy: Weekly Science News

Posted by MD Biosciences on Nov 6, 2018 11:00:00 AM

MD Biosciences providing up-to-date news coverage compiling posts from science journals including British Journal of Cancer, Proceedings of the National Academy of Sciences, Neuroscience News, ScienceDaily, Science Translational Medicine and Stat News, reporting fascinating and innovative discoveries happening all over the world across a wide variety of disciplinary areas. Skim the titles below to catch up on what is happening and to learn what the team at MD Biosciences is reading about. Follow the links to read more about something that catches your eye! 

Read More

Topics: Neuro/CNS, cancer/tumor, Biomarkers, Academic Research, Immuno-Oncology, Biotechnology, Neuroscience

Changing the Future of Biomarkers and Human Disease Treatments: Biotechnology News

Posted by MD Biosciences on Nov 1, 2018 11:00:00 AM

MD Biosciences providing up-to-date news coverage compiling posts from science journals including Nature Cell Biology, Sci News, Journal of PLOS Biology, Medical Press, ScienceDaily and PhysOrg, reporting fascinating and innovative discoveries happening all over the world across a wide variety of disciplinary areas. Skim the titles below to catch up on what is happening and to learn what the team at MD Biosciences is reading about. Follow the links to read more about something that catches your eye! 

Read More

Topics: Neuro/CNS, cancer/tumor, Biomarkers, Academic Research, Immuno-Oncology, Biotechnology, Neuroscience

Weekly Science News: Gene Discovery and Advancing Cell Regeneration Therapies

Posted by MD Biosciences on Oct 2, 2018 11:00:00 AM

MD Biosciences providing up-to-date news coverage compiling posts from science journals including GigaScience, Nature Communications, Nature Biomedical Engineering, ScienceDaily and Scientific Reports reporting fascinating and innovative discoveries happening all over the world across a wide variety of disciplinary areas. Skim the titles below to catch up on what is happening and to learn what the team at MD Biosciences is reading about. Follow the links to read more about something that catches your eye! 

Read More

Topics: cancer/tumor, Biomarkers, Academic Research, phenotypes, epigenomic, Metastatic tumor

Weekly Highlights: Stem Cells and Biomarkers Paving Advancements in Biotechnology

Posted by MD Biosciences on Sep 25, 2018 11:00:00 AM

MD Biosciences providing up-to-date news coverage compiling posts from science journals including Cell, Cancer Therapy Advisor, Nature Microbiology, Science Translational Medicine, ScienceDaily and Science reporting fascinating and innovative discoveries happening all over the world across a wide variety of disciplinary areas. Skim the titles below to catch up on what is happening and to learn what the team at MD Biosciences is reading about. Follow the links to read more about something that catches your eye! 

Read More

Topics: cancer/tumor, Biomarkers, Academic Research, phenotypes, epigenomic, Metastatic tumor

Genome Sequencing and Immunotherapies: Weekly News

Posted by MD Biosciences on Sep 18, 2018 11:00:00 AM

MD Biosciences providing up-to-date news coverage compiling posts from science journals including Cancer Research, Sci News, Nature GeneticsBritish Journal of Pharmacology and Science reporting fascinating and innovative discoveries happening all over the world across a wide variety of disciplinary areas. Skim the titles below to catch up on what is happening and to learn what the team at MD Biosciences is reading about. Follow the links to read more about something that catches your eye! 

Read More

Topics: Inflammation, Neuro/CNS, cancer/tumor, dermatitis, preclinical research, Biotechnology

Biomarkers, Drug Discovery and Immunotherapy: Weekly Highlights

Posted by MD Biosciences on Sep 6, 2018 11:00:00 AM

MD Biosciences providing up-to-date news coverage compiling posts from science journals including Nature, Nature Communications and Cell, reporting fascinating and innovative discoveries happening all over the world across a wide variety of disciplinary areas. Skim the titles below to catch up on what is happening and to learn what the team at MD Biosciences is reading about. Follow the links to read more about something that catches your eye! 

                                                                                     image source: wildpixel/Getty Images
Read More

Topics: cancer/tumor, Biomarkers, Life Science, Discoveries, preclinical research

AMPK: Linking Metabolism & Cancer

Posted by MD Biosciences on Oct 3, 2016 3:32:13 PM

Cancer: The Metabolic Link

After decades of research into the genetics of cancer, there has been amassing evidence associating these cancer causing genes, or oncogenes, to cellular metabolism and bioenergetics regulation. This metabolic link serves to facilitate the rapid growth and survival that is characteristic of many cancer cells. Given this, it is not surprising that obesity, already known to exacerbate metabolic disorders, is also affiliated with increased cancer risk. As obesity approaches pandemic levels, understanding the mechanisms involved between cancer and organism metabolism becomes increasingly important.

Read More

Topics: cancer/tumor, AMPK

Immunotherapy, the Answer to Cancer?

Posted by MD Biosciences on Aug 30, 2016 3:46:55 PM

Immunoinhibitory checkpoints — act as the BREAKS of an immune system — shutting down the adaptive immune response. While inhibitory checkpoints such as PD-1 and CTLA-4 are important in the long-term prevention of auto-immune disorders, cancer will often take advantage of these signaling molecules to avoid destruction by the host immune system. In light of this, development of antagonistic monoclonal antibodies to block these signaling molecules has led to the FDA approval of both an anti-CTLA-4 monoclonal antibody, ipilimumab, and two anti-PD-1 antibodies, pembrolizumab and nivolumab, for the treatment of cancer.

These immunotherapeutic treatments have demonstrated versatility in the treatment of multiple cancer types. Nivolumab — first approved for the treatment of metastatic melanoma in late 2014 — has since been approved for treating advanced lung cancer and renal cell carcinoma, further illustrating the versatility of this immunotherapeutic approach. While demonstrating promise as single agents, the efficacious effects of these therapies are dramatically improved when they are used in combination with other chemo-radiation, or immuno-therapies. This exciting area of therapeutic potential is still in its infancy and continues to grow as more and more is learned about harnessing the body’s own capabilities to destroy cancer.

Read More

Topics: cancer/tumor, Immuno-Oncology

What is the Impact of Vendor Animal Microbiomes on Disease?

Posted by MD Biosciences on Apr 22, 2016 3:35:00 PM

On Thusday, MD Biosciences' Lead Scientist Britnie James, Ph.D. presented at the 2nd Annual Translational Microbiome Conference held in Boston, MA.  Her talk entitled "Understanding the Impact of Animal Vendors and the Microbiome in Tumor Progression and Treatment in a Model of Metastatic Breast Cancer" highlights the importance of the role of the micorbiome in disease progression and treatment. 

Read More

Topics: Inflammation, cancer/tumor, Microbiome

2015 Recap|Clinical Diagnostics & Translational Research

Posted by MD Biosciences on Dec 17, 2015 5:57:36 PM

As we wind down to years end, we at MD Biosciences would like to thank everyone, especially our collaborators, for making this year a success. We have undergone significant growth that we expect to continue throughout the upcoming year.

Read More

Topics: Pain, Inflammation, Neuro/CNS, post-operative pain, cancer/tumor, Microbiome, Biomarkers, CLIA, Neuropathy